|
RRP15 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.70397029819469E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.1325610428421E-13 |
| Normal-vs-Stage2 |
1.60019999995153E-06 |
| Normal-vs-Stage3 |
4.29199997764584E-09 |
| Normal-vs-Stage4 |
7.90109977444331E-10 |
| Stage1-vs-Stage2 |
5.040800E-01 |
| Stage1-vs-Stage3 |
6.821800E-01 |
| Stage1-vs-Stage4 |
3.539600E-01 |
| Stage2-vs-Stage3 |
7.557600E-01 |
| Stage2-vs-Stage4 |
2.177400E-01 |
| Stage3-vs-Stage4 |
2.792600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.66044955562938E-12 |
| Normal-vs-AfricanAmerican |
2.619300E-03 |
| Normal-vs-Asian |
9.67929999484696E-08 |
| Caucasian-vs-AfricanAmerican |
9.682400E-02 |
| Caucasian-vs-Asian |
8.789000E-01 |
| AfricanAmerican-vs-Asian |
1.473000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.10622663543836E-14 |
| Normal-vs-Female |
9.64939239622709E-12 |
| Male-vs-Female |
2.634400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.40751904260151E-12 |
| Normal-vs-Age(41-60Yrs) |
3.54094531473947E-12 |
| Normal-vs-Age(61-80Yrs) |
1.40360000289164E-08 |
| Normal-vs-Age(81-100Yrs) |
1.920470E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.843800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.309800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.955600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.316400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.682200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.397400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.530800E-01 |
| Classical-VS-Follicular |
1.817550E-03 |
| Classical-VS-Other |
2.465700E-02 |
| Classical-VS-Normal |
2.15670037384541E-10 |
| Tall-VS-Follicular |
4.257600E-01 |
| Tall-VS-Other |
1.102360E-01 |
| Tall-VS-Normal |
9.37050000038298E-07 |
| Follicular-VS-Other |
2.679600E-01 |
| Follicular-VS-Normal |
9.89452964006432E-12 |
| Other-VS-Normal |
5.74979999999892E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.73270336651422E-13 |
| Normal-vs-N1 |
1.3212000382623E-09 |
| N0-vs-N1 |
6.386000E-01 |
|
|
